Histochemistry and Cell Biology

, Volume 106, Issue 6, pp 543–550 | Cite as

CD44 isoform expression in the diffuse neuroendocrine system. I. Normal cells and hyperplasia

  • W. K. F. Seelentag
  • P. Komminoth
  • P. Saremaslani
  • Ph. U. Heitz
  • J. Roth
Original Paper


Isoforms of the transmembrane glycoprotein CD44, which are generated by alternative splicing of nine variant exons, have been implicated in tumor cell adhesion, invasion and metastatic spread and may be indicators of the degree of tumor differentiation. Since little is known about the distribution of CD44 in non-neoplastic neuroendocrine cell types, we systematically investigated 42 samples of tissue from different organs, including the pituitary gland, thyroid, parathyroid, adrenal gland, lung, pancreas, stomach, duodenum, jejunum, ileum, appendix, and colon, immunohistochemically for the expression of CD44 standard and variant exon-encoded gene products (CD44v3, v4, v5, v6, v9). Furthermore, double immunolabeling for CD44 and a variety of peptide hormones was applied to characterize the different neuroendocrine cell types. Our results show that neuroendocrine cells derived from the neuroectoderm lack CD44 immunoreactivity. However, those originated from the endoderm exhibit a variable CD44 immunostaining which is related to their anatomical localization and the degree of differentiation irrespective of the hormone produced. Furthermore, we demonstrate that CD44 positive neuroendocrine cells predominantly express CD44 isoforms of the epithelial type and that hyperplastic clusters of neuroendocrine cells of pancreatic ducts express CD44 most probably as a sign of dedifferentiation.


CD44 Expression Neuroendocrine Cell Neural Cell Adhesion Molecule Pancreatic Polypeptide Polysialic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abbasi AM, Chester KA, Talbot IC, Macpherson AS, Boxer G, Forbes A, Malcolm AD, Begent RH (1993) CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells. Eur J Cancer 29A: 1995–2002PubMedCrossRefGoogle Scholar
  2. Adams JC (1981) Heavy metal intensification of DAB-based HRP reaction product. J Histochem Cytochem 29: 775–775PubMedGoogle Scholar
  3. Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I (1996) Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol 132: 1199–1208PubMedCrossRefGoogle Scholar
  4. Bennett KL, Modrell B, Greenfield B, Bartolazzi A, Stamenkovic I, Peach R, Jackson DG, Spring FA, Aruffo A (1995) Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol 131: 1623–1633PubMedCrossRefGoogle Scholar
  5. Chaudhry A, Gobl A, Eriksson B, Skogseid B, Oberg K (1994) Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors. Cancer Res 54: 981–986.PubMedGoogle Scholar
  6. Dayal Y (1983) Endocrine cells of the gut and their neoplasms. In: Norris HT (ed) Pathology of the colon, small intestine and anus. Churchill Livingstone, New York, pp 267–300Google Scholar
  7. DeLellis R, Dayal Y (1992) Neuroendocrine system. In: Sternberg SS (ed). Histology for pathologists. Raven Press, New York, pp 347–362Google Scholar
  8. Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A, Simmons DL (1994) Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms Cancer Res 54: 4539–4546PubMedGoogle Scholar
  9. Günthert U (1993) CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 184: 47–63PubMedGoogle Scholar
  10. Günthert U (1996) CD44 in malignant disorders. Curr Top Microbiol Immunol 213: 271–285PubMedGoogle Scholar
  11. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13–24PubMedCrossRefGoogle Scholar
  12. Haynes BF, Telen MJ, Hale LP, Denning SM (1989) CD44—a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 10:423–428 [erratum 11:80]PubMedCrossRefGoogle Scholar
  13. Hofmann M, Rudy W, Günthert U, Zimmer SG, Zawadzki V, Zöller M, Lichtner RB, Herrlich P, Ponta H (1993) A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res 53: 1516–1521PubMedGoogle Scholar
  14. Kogerman P, Sy MS, Culp LA (1996) Oncogene-dependent expression of CD44 in Balb/c 3T3 derivatives: correlation with metastatic competence. Clin Exp Metastasis 14: 73–82PubMedGoogle Scholar
  15. Komminoth P, Roth J, Lackie PM, Bitter Suermann D, heitz PU (1991) Polysialic acid of the neural cell adhesion molecule distinguishes small cell lung carcinoma from carcinoids. Am J Pathol 139: 297–304PubMedGoogle Scholar
  16. Komminoth P, Roth J, Saremaslani P, Matias Guiu X, Wolfe HJ, Heitz PU (1994) Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions. Am J Surg Pathol 18: 399–411PubMedCrossRefGoogle Scholar
  17. Komminoth P, Roth J, Schröder S, Saremaslani P, Heitz PU (1995) Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors. Lab Invest 72: 424–431PubMedGoogle Scholar
  18. Komminoth P, Seelentag WKF, Saremaslami P, Günthert U, Heitz PU, Roth J (1996) CD44 isoform expression in the diffuse neuroendocrine system. II. Benign and malignant tumors. Histochem Cell Biol 106: 551–562PubMedCrossRefGoogle Scholar
  19. Le Douarin NM (1982) The neural crest. Cambridge University Press, Cambridge UKGoogle Scholar
  20. Le Douarin NM (1988) On the origin of pancreatic endocrine cells. Cell 53: 169–171PubMedCrossRefGoogle Scholar
  21. Lesley J, Hyman R, Kincade PW (1993) CD44 and its interaction with extracellular matrix. Adv Immunol 54: 271–335PubMedCrossRefGoogle Scholar
  22. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U (1994) Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124: 71–82PubMedCrossRefGoogle Scholar
  23. Roth J, Taatjes DJ, Wagner P, Weisgerber C, Heitz PU, Goridis C, Bitter-Suermann D (1988) Reexpression of poly(sialic acid) units of the neural cell adhesion molecule in Wilms tumor. Proc Natl Acad Sci USA 85: 2999–3003PubMedCrossRefGoogle Scholar
  24. Roth J, Zuber C, Komminoth P, Scheidegger EP, Warhol MJ, Bitter-Suermann D, Heitz PU (1993) Expression of polysialic acid in human tumors and its significance for tumor growth. In: Roth J, Rutishauser U, Troy FA (eds) Polysialic acid: from microbes to man. Birkhäuser, Basel, pp 335–348Google Scholar
  25. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89: 12160–12164PubMedCrossRefGoogle Scholar
  26. Seelentag WKF, Futo E, Saremaslani P, Günthert U, Heitz PU, Roth J (1996) CD44 standard and variant isoform expression in normal human epidermis and skin appendages and epidermis. Histochem Cell Biol 106: 283–289.PubMedCrossRefGoogle Scholar
  27. Sy MS, Liu D, Schiavone R, Ma J, Miori H, Guo Y (1996) Interactions between CD44 and hyaluronic acid: their role in tumor growth and metastasis. Curr Top Microbiol Immunol 213: 129–153PubMedGoogle Scholar
  28. Terpe HJ, Stark H, Prehm P, Günthert U (1994) CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues. Histochemistry 101: 79–89PubMedCrossRefGoogle Scholar
  29. Wang C, Tammi M, Tammi R (1992) Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry 98: 105–112PubMedCrossRefGoogle Scholar
  30. Werner M, von Wasielewski R, Komminoth P (1996) Antigen retrieval, signal amplification and intensification in immunohistochemistry. Histochem Cell Biol 105: 253–260PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • W. K. F. Seelentag
    • 1
  • P. Komminoth
    • 1
  • P. Saremaslani
    • 1
  • Ph. U. Heitz
    • 1
  • J. Roth
    • 1
  1. 1.Division of Cell and Molecular Pathology, Department of PathologyUniversity of ZürichZürichSwitzerland

Personalised recommendations